The sodium-glucose co-transporter 2 inhibitor empagliflozin improves diabetes-induced vascular dysfunction in the streptozotocin diabetes rat model by interfering with oxidative stress and glucotoxicity (Q34524690)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | The sodium-glucose co-transporter 2 inhibitor empagliflozin improves diabetes-induced vascular dysfunction in the streptozotocin diabetes rat model by interfering with oxidative stress and glucotoxicity |
scientific article |
Statements
1 reference
The sodium-glucose co-transporter 2 inhibitor empagliflozin improves diabetes-induced vascular dysfunction in the streptozotocin diabetes rat model by interfering with oxidative stress and glucotoxicity (English)
1 reference
Matthias Oelze
Swenja Kröller-Schön
Philipp Welschof
Thomas Jansen
Michael Hausding
Yuliya Mikhed
Paul Stamm
Michael Mader
Elena Zinßius
Saule Agdauletova
Anna Gottschlich
Sebastian Steven
Eberhard Schulz
Eric Mayoux
17 November 2014
1 reference
17 November 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference